Skip to content

Influence of Platelet Concentrates on Wound Healing

The Influence of Autologous Platelet Concentrates on Human Keratinocyte Proliferation in Vitro and Wound Healing in Vivo

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03667638
Enrollment
5
Registered
2018-09-12
Start date
2016-11-30
Completion date
2017-12-31
Last updated
2018-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Platelet-Rich Plasma, Wound Healing Delayed

Keywords

Platelet-Rich Plasma, Laser Doppler Imaging, Growth Factors, Wound Healing, Chronic wound healing disorder, Wound quality of life

Brief summary

Chronic soft tissues defects can extend into the fat layer or even deeper and can cause functional disadvantages. Split-thickness skin grafts (STSGs) used to cover these wounds have varying success rates. To improve wound healing in chronic wounds the authors have studied the application of autologous platelet concentrates in a human keratinocyte culture model in vitro and in a combination with surgical procedures in vivo as second line therapy in patients with initially failed wound closure.

Detailed description

For in vitro testing on keratinocytes a platelet-mediator concentrate (PMC) was processed with a commercially available bed-side system (ATR®, Curasan, Germany). In a clinical study soft tissue defects (n=5) were treated using a combination of surgical debridement and autologous platelet rich plasma (PRP). Time of healing as determined by epithelization as well as Laser Doppler Imaging to visualize blood flow were analyzed. Additionally, changes in ease of surgical wound closure were determined. Finally, the quality of life of patients was assessed using a validated questionnaire.

Interventions

COMBINATION_PRODUCTPlatelet-Rich Plasma

Adding PRP to wound bed during surgical debridement

Sponsors

Hannover Medical School
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* exposed tendons, ligaments or bone for \>3 weeks * no healing tendency

Exclusion criteria

* sepsis * intensive care treatment * continuous smoking * pregnancy or breast feeding women * participants of other studies.

Design outcomes

Primary

MeasureTime frameDescription
Wound Closure4 weeksArea of wound closure in % compared to initial size

Secondary

MeasureTime frameDescription
Blood Flow4 weeksBlood flow measured in wound margins and wound bed compared to regular skin measured using Laser Doppler Imaging
Wound Quality of Life21 daysQuality of patients' life measured using Wound-QoL® Questionnaire before and after Intervention. Seventeen items are included in the Wound-QoL, which could be attributed to three subscales on everyday life, body, and psyche. The paper presents the overall score. A higher value correlates with more wound related burden, meaning a lower value indicates higher qulitiy of life. More information: https://www.ncbi.nlm.nih.gov/pubmed/24899053
Ease of surgical wound closure21 daysEstimated ease of surgical wound closure. The patients'wound was discussed by at least two surgeons to obtain agreement on a 14- point Ease of Closure scale. This was done on day 0 as well as day 21. The scale ranged from a score of 0, meaning the wound was closed or so small as to require no closure technique, to a score of 13, meaning that it was not possible to close the wound with known reconstructive surgical techniques. A higher value therefore correlates with more complex surgery. More information: https://www.ncbi.nlm.nih.gov/pubmed/10231510

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026